<DOC>
	<DOCNO>NCT00968305</DOCNO>
	<brief_summary>Asthma common childhood chronic illness generally severe African Americans . The investigator attempt determine whether specific immune marker associate lung function asthma severity .</brief_summary>
	<brief_title>Interleukin ( IL ) -13 Marker Pediatrics Asthma</brief_title>
	<detailed_description>This study examine relationship Interleukin ( IL ) -13 phytohemagglutinin-activated polymorphonuclear blood cell asthma severity , lung function ( measure FEV1 % ) , total serum IgE level African American child clinically diagnose asthma</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>AfricanAmerican race , born U.S. Age 815 year Clinical diagnosis asthma Subject able understand follow verbal instruction English Asthma exacerbation 4 week precede research visit Oral/IV steroid use 4 week precede research visit Upper low respiratory tract infection 4 week precede research visit Antibiotic use 4 week precede research visit Use shortacting bronchodilator 6 hour prior spirometry ( lung function test ) Use longacting bronchodilator 12 hour prior spirometry ( lung function test )</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>African American child stable asthma</keyword>
	<keyword>Asthma severity</keyword>
	<keyword>Interleukin 13 PHA stimulate PBMC</keyword>
	<keyword>Lung function ( FEV1 % )</keyword>
	<keyword>Total serum IgE</keyword>
	<keyword>Pediatrics</keyword>
</DOC>